Breast Cancer: IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15‐Dependent BMI1 Stability (Adv. Sci. 1/2020)

In article https://doi.org/10.1002/advs.201901728, Suling Liu and co‐workers report that the “decoy receptor” IL‐1 receptor 2 (IL1R2) is highly expressed on the most tumorigenic intermediate‐state breast tumor initiation cells (BTICs), which fall in between the epithelial‐like state and mesenchymal‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lixing, Qiang, Jiankun, Yang, Xiaoli, Wang, Dong, Rehman, Adeel ur, He, Xueyan, Chen, Weilong, Sheng, Dandan, Zhou, Lei, Jiang, Yi‐zhou, Li, Tao, Du, Ying, Feng, Jing, Hu, Xin, Zhang, Jian, Hu, Xi‐chun, Shao, Zhi‐ming, Liu, Suling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Inside Front Cover
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947498/
http://dx.doi.org/10.1002/advs.202070002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947498/
http://dx.doi.org/10.1002/advs.202070002

Ejemplares similares